focus -WSS

focus

author：leisure time 2025-10-02 18:05:29 - browse：1

John Crowley pictured with his daughter Megan Crowley — health policy news from STAT — John Crowley pictured with his daughter Megan. Crowley family

WASHINGTON — The Biotechnology Innovation Organization has chosen longtime biotech executive and rare disease advocate John Crowley as its new CEO, the organization announced Tuesday.

Crowley came to biotech when his children were diagnosed with a rare genetic neuromuscular disease. He started working at Bristol Myers Squibb, and started Novazyme, which was eventually successful in creating an enzyme replacement therapy for Pompe disease. He later started and worked for several different biotech companies, most recently with Amicus Therapeutics, which had a drug approved to treat the disease in September.

The trade association’s board chair, Ted Love, served on the board of the company.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum
Next article： Texas Medical Board asked to define abortion emergency exception

focus

WSS

3 questions for the future of Biden's cancer moonshot

The future of health care in the House

AI can decode, harness the power of the humane immune system

What to expect at HLTH 2023, the health care industry conference

A single Democrat is willing to weaken Medicare negotiation power

Gritstone Bio's cancer vaccine test, and more on Novartis' deal

hotspot

focus

Wikipedia

Guidelines to prevent youth baseball injuries need more muscle

Surgery pushed Ben Carson to fame

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Readout Newsletter: Amgen, Regeneron, BGI Group and more

Hepatitis C has a cure — but many Americans still lack access to it

Readout Newsletter: Amgen, Regeneron, BGI Group and more

Supreme Court strikes down use of affirmative action

When women are denied an abortion, their children fare worse than peers

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Gritstone Bio's cancer vaccine test, and more on Novartis' deal

focus

Readout LOUD: Venture capital, Gilead, and more M&A

Vyjuvek, a gene therapy for skin wounds, restored vision in one boy

FDA authorizes Novavax’s updated Covid

Cano Health’s bankruptcy is a warning for Medicare Advantage

AI gets buy

FDA authorizes Novavax’s updated Covid

hotspot

focus

knowledge

knowledge